Company
AKCEA THERAPEUTICS, INC. (0001662524)
Standardized SEC financial data for AKCEA THERAPEUTICS, INC. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001662524 · Pharmaceutical Preparations.
Operating margin
-185.7%
Net margin
42.1%
Revenue growth (YoY)
49.5%
Return on equity
5.0%
Free cash flow
$222.2M
Current ratio
11.83×
Ratios for fiscal year 2018, standardized from SEC filings.
Income statement
| USD | FY2016 | FY2017 | FY2018 | FY2019 |
|---|---|---|---|---|
| Revenue | $0 | $55.2M | $64.9M | — |
| R&D expense | $68.5M | $126.9M | $130.3M | — |
Balance sheet
| USD | FY2016 | FY2017 | FY2017 | FY2018 | FY2019 |
|---|---|---|---|---|---|
| Cash & equivalents | $7.9M | — | $58.4M | $252.6M | $463.7M |
| Inventory | — | — |
Cash flow
| USD | FY2016 | FY2017 | FY2018 | FY2019 |
|---|---|---|---|---|
| Operating cash flow | -$55.4M | -$36.2M | -$202.9M | $223.8M |
| Capital expenditures | $179K | $9K | $1.1M | $1.6M |
Get 0001662524 data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0001662524/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0001662524/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"